We first analyzed by RPPA a series of signalling pathways in pancreatic cancer cells, expressing or not expressing SMAD4, and repeatedly stimulated with EGF “in vitro” in order to simulate “in vivo” conditions. The gene discussed is SMAD4; the disease is pancreatic neoplasm.